Details for New Drug Application (NDA): 074700
✉ Email this page to a colleague
The generic ingredient in BUMETANIDE is bumetanide. There are six drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the bumetanide profile page.
Summary for 074700
Tradename: | BUMETANIDE |
Applicant: | Sandoz |
Ingredient: | bumetanide |
Patents: | 0 |
Pharmacology for NDA: 074700
Physiological Effect | Increased Diuresis at Loop of Henle |
Medical Subject Heading (MeSH) Categories for 074700
Suppliers and Packaging for NDA: 074700
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
BUMETANIDE | bumetanide | TABLET;ORAL | 074700 | ANDA | Sandoz Inc | 0185-0128 | 0185-0128-01 | 100 TABLET in 1 BOTTLE (0185-0128-01) |
BUMETANIDE | bumetanide | TABLET;ORAL | 074700 | ANDA | Sandoz Inc | 0185-0128 | 0185-0128-05 | 500 TABLET in 1 BOTTLE (0185-0128-05) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 0.5MG | ||||
Approval Date: | Nov 21, 1996 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 1MG | ||||
Approval Date: | Nov 21, 1996 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 2MG | ||||
Approval Date: | Nov 21, 1996 | TE: | AB | RLD: | No |
Complete Access Available with Subscription